Topical paromomycin for New World cutaneous leishmaniasis

BACKGROUND: Paromomycin-based topical treatments were shown to be effective in curing cutaneous leishmaniasis (CL) lesions caused by Leishmania major in Tunisia. Cure rates of an index lesion were approximately 80%. As a follow on, we conducted a similar Phase 3 trial in Panama to demonstrate the ef...

Descripción completa

Detalles Bibliográficos
Autores principales: Sosa, Néstor, Pascale, Juan Miguel, Jiménez, Ana I., Norwood, Jeanne A., Kreishman-Detrick, Mara, Weina, Peter J., Lawrence, Kendra, McCarthy, William F., Adams, Ryan C., Scott, Charles, Ransom, Janet, Tang, Douglas, Grogl, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497224/
https://www.ncbi.nlm.nih.gov/pubmed/31048871
http://dx.doi.org/10.1371/journal.pntd.0007253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6497224/
https://www.ncbi.nlm.nih.gov/pubmed/31048871
http://dx.doi.org/10.1371/journal.pntd.0007253

Ejemplares similares